PEPTIDE SYNTHESIS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECAST (2022 - 2027)

SDKI Inc. published a new report on the Peptide Synthesis Market-Global Forecast 2023 on April 14, 2021. This study includes the statistical and analytical approaches needed to grow the peptide synthesis market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-110029

The peptide synthesis market is estimated to reach US $ 426.4 million by 2023 from US $ 310.5 million in 2018 and is projected to grow at a CAGR of 6.5% during the forecast period. Factors such as increased use of peptides in pharmaceuticals, increased research activity, availability of funds for R & D, and the development of advanced peptide synthesizers are expected to drive market growth.

Market segment

The peptide synthesis market is divided by product (reagent, synthesizer, chromatography), technology (solid phase, liquid phase, hybrid / recombinant), end user (pharmaceutical / biotechnology, CRO), and region. Will be done. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

The solid-phase segment has the largest market share and is expected to grow at the largest CAGR during the forecast period.

Based on the technology, the peptide synthesis market is divided into solid phase, liquid phase, and hybrid / recombinant technology. Solid-phase synthesis is associated with many advantages such as ease of operation, ease of purification, short production cycles, high levels of automation, and the ability to synthesize long peptides with small amounts of amino acids. This advantage is expected to facilitate the adoption of solid phase synthesis.

Report sample URL
https://www.sdki.jp/sample-request-110029

The contract development and manufacturing organization segment is projected to grow at a significant CAGR during the forecast period.

Based on the end user, the market is divided into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes. The contract development and manufacturing organization segment is expected to grow at a maximum CAGR during the forecast period. Increasing demand for cost-effective peptide synthesis services in drug development activities and life sciences research is driving growth in this segment.

Regional Overview

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

North America dominated the peptide synthesis market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East / Africa. North America has the largest share of the peptide synthesis market. This large share may be due to the high prevalence of chronic diseases, increased investment in the development of structure-based drug designs, and the growth of research in the area of ​​genomics and proteomics in the region.

Details of the survey report
https://www.sdki.jp/reports/peptide-synthesis-market/110029

Major key players on the market

Key players in the peptide synthesis market include GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Swedish), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden). , Advanced ChemTech (USA), Merck KGAA (Germany), New England Peptide (USA) and more. The study includes a detailed competitive analysis of these major companies in the peptide synthesis market, corporate profiles, recent developments, and key market strategies.

Contact Us:

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jpTokyo, Shibuya-ku, Japan

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.